Zhenzhen Ye, OD
Optometry · Los Altos
- Medicare standing
- Clear
- Enrolled, allowed to bill and order, not excluded
- Plans that list them
- 1
- 1 carrier
- Offices
- 2
Offices
2 locations · Sutter Bay Medical Foundation · 3,783 clinicians in this group
Plans that list them
1 plan · 1 carrier
A missing listing does not mean out of network. Directories change, and a listing does not cover every office. Call Dr. Ye’s office to confirm they take your plan. Ask about the office you use, its medical group, referrals and appointments.
| DualConnect (HMO D-SNP) | Santa Clara Family Health Plan | Listed | Sep 1, 2026 |
Original Medicare doctor bills
$9,767
Medicare paid this office $9,767 for 65 people.
This is what Medicare paid the clinician — not Medicare Advantage, and not the pharmacy.
| Return visit (30+ min) | 25 | $3,463 | $124 |
| Short return visit (20+ min) | 17 | $1,500 | $88 |
| New patient visit (30+ min) | 11 | $1,107 | $101 |
Who their Medicare patients are
65 Original Medicare patients in 2024. Average age 78 · Under 65 0% · 85 and older 19% · Women 52% · Health risk score 0.92. At or below the middle of the specialty; the typical optometry clinician is at 0.97.
Conditions among them: High blood pressure 71% · Diabetes 37% · Coronary heart disease 28% · Cancer 18%.
The office billed $35,788, Medicare allowed $12,250 and paid $9,767; for 107 services of 14 kinds.
Original Medicare patients only. A risk score of 1.0 is the average Medicare patient; higher means sicker. Any count under 11 is hidden.
Medicaid work
$2,274 in 2024
Medicaid paid $2,274 for 576 billed services this clinician did in 2024, up to 50 people in a month for one service.
Medicaid and CHIP claims where this clinician did the service, fee-for-service and managed care together. Any month with fewer than 11 patients is hidden, so small Medicaid practices undercount.
| OPH SVCS MEDICAL XM&EVAL COMPRE NEW PT 1/> VST | 157 | $1,136 |
| Frames, purchases | 132 | $518 |
| Fitting of monofocal spectacles | 87 | $310 |
| DETERMINATION REFRACTIVE STATE | 188 | $274 |
| OPH SVCS MEDICAL XM&EVAL COMPRE EST PT 1/>VST | 12 | $36 |
| 2024 | 576 | 5 | 50 | $2,274 |
| 2023 | 242 | 4 | 31 | $507 |
| 2022 | 95 | 3 | 24 | $112 |
See the largest Medicaid services in earlier years
2023
| OPH SVCS MEDICAL XM&EVAL COMPRE NEW PT 1/> VST | 75 | $320 |
| Frames, purchases | 66 | $96 |
| DETERMINATION REFRACTIVE STATE | 84 | $72 |
| Fitting of monofocal spectacles | 17 | $19 |
2022
| DETERMINATION REFRACTIVE STATE | 51 | $58 |
| OPH SVCS MEDICAL XM&EVAL COMPRE NEW PT 1/> VST | 17 | $36 |
| Frames, purchases | 27 | $19 |
Money from drug and device companies
$893 in 2025
| 2025 | 7 | 23 | None | $893 |
| 2024 | 2 | 2 | None | $166 |
| 2022 | 3 | 8 | None | $634 |
| 2021 | 1 | 2 | None | $158 |
| 2019 | 3 | 3 | None | $246 |
Paid work is consulting, speaking, honoraria and royalties, as opposed to meals and travel.
A payment is not proof that care is biased.
| Tarsus Pharmaceuticals | Xdemvy | $258 | 13 payments
|
| Bausch & Lomb Americas | Miebo | $233 | 3 payments
|
| Alcon Vision | Hydrus Microstent | $173 | 2 payments
|
| Abbvie | Durysta | $152 | 2 payments
|
| Amgen | Tepezza | $32 | 1 payment
|
| Oyster Point Pharma | Tyrvaya | $26 | 1 payment
|
See all 23 published payments
| Tarsus Pharmaceuticals | Meals · 2025-12-09 | Xdemvy | $10 |
| Tarsus Pharmaceuticals | Meals · 2025-12-02 | None | $14 |
| Tarsus Pharmaceuticals | Meals · 2025-12-01 | Xdemvy | $7 |
| Tarsus Pharmaceuticals | Meals · 2025-11-25 | Xdemvy | $8 |
| Thea Pharma | Meals · 2025-11-13 | Iyuzeh | $20 |
| Tarsus Pharmaceuticals | Meals · 2025-11-11 | Xdemvy | $2 |
| Tarsus Pharmaceuticals | Meals · 2025-11-11 | Xdemvy | $3 |
| Tarsus Pharmaceuticals | Meals · 2025-11-11 | Xdemvy | $2 |
| Bausch & Lomb Americas | Meals · 2025-10-29 | Miebo | $125 |
| Tarsus Pharmaceuticals | Meals · 2025-10-28 | Xdemvy | $5 |
| Alcon Vision | Meals · 2025-10-21 | Tryptyr | $24 |
| Oyster Point Pharma | Meals · 2025-10-14 | Tyrvaya | $26 |
| Abbvie | Meals · 2025-10-09 | Durysta | $119 |
| Tarsus Pharmaceuticals | Meals · 2025-10-08 | Xdemvy | $36 |
| Tarsus Pharmaceuticals | Meals · 2025-10-06 | Xdemvy | $8 |
| Tarsus Pharmaceuticals | Meals · 2025-09-29 | Xdemvy | $9 |
| Abbvie | Meals · 2025-08-26 | Lumigan | $33 |
| Amgen | Meals · 2025-08-25 | Tepezza | $32 |
| Tarsus Pharmaceuticals | Meals · 2025-05-20 | None | $146 |
| Bausch & Lomb Americas | Meals · 2025-04-14 | Vyzulta | $8 |
| Alcon Vision | Meals · 2025-03-14 | Hydrus Microstent | $149 |
| Tarsus Pharmaceuticals | Meals · 2025-03-12 | Xdemvy | $10 |
| Bausch & Lomb Americas | Meals · 2025-01-10 | Miebo | $100 |
See earlier years (2024, 2022, 2021, 2019)
2024: $166
| Tarsus Pharmaceuticals | Xdemvy | $148 | 1 payment
|
| Johnson & Johnson Vision Care | None | $18 | 1 payment
|
2022: $634
| Johnson & Johnson Vision Care | Acuvue | $448 | 5 payments
|
| Glaukos | Kxl System | $164 | 2 payments
|
| Kala Pharmaceuticals | Inveltys | $22 | 1 payment
|
2021: $158
| Johnson & Johnson Vision Care | Acuvue | $158 | 2 payments
|
2019: $246
| Bausch & Lomb a division of Bausch Health US | Vyzulta | $125 | 1 payment
|
| Visioneering Technologies | None | $96 | 1 payment
|
| Sight Sciences | Tearcare | $26 | 1 payment
|
Professional record
- NPI
- 1972097244
- Licence
- CA 34195TLG, NY TUV008758
- Gender
- Female
More record details
- Sole proprietor
- No
- Taxonomy
- Federal specialty code 152W00000X (152W00000X)
- Mailing address
- 57 El Camino Real, San Carlos, CA, 94070
- NPI first listed
- 2018-06-19
- NPI last updated
- 2019-07-30
This is when the NPI record was last certified, not a medical board exam.